本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

爵士制药

136.06
+1.811.35%
盘后136.060.00000.00%16:10 EDT
成交量:36.77万
成交额:4,984.41万
市值:82.53亿
市盈率:-20.51
高:136.61
开:134.42
低:133.41
收:134.25
52周最高:148.06
52周最低:95.49
股本:6,065.88万
流通股本:5,865.43万
量比:0.68
换手率:0.63%
股息:- -
股息率:- -
每股收益(TTM):-6.6339
每股收益(LYR):9.06
净资产收益率:-10.84%
总资产收益率:5.19%
市净率:2.23
市盈率(LYR):15.02

数据加载中...

2025/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

重要事件披露

Form 8-K - Current report
2025/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/30

SEC问询函

Form CORRESP - Correspondence
2025/07/25

重要事件披露

Form 8-K - Current report
2025/07/10

重要事件披露

Form 8-K - Current report
2025/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]